TCG Crossover Management, LLC Diversified Active

CIK: 0001839948 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value ($000): $609,794 (100.0% shares, 0.0% debt)

Holdings (22)

IVERIC BIO INC 15.8%
Value ($000) $96,337 Shares 2,448,829 Est. Cost $17.57 Unrealized
GERN GERON CORP 12.4%
Value ($000) $75,723 Shares 23,589,779 Est. Cost $1.89 Unrealized +50.9%
COGT COGENT BIOSCIENCES INC 10.9%
Value ($000) $66,672 Shares 5,631,042 Est. Cost $9.54 Unrealized +20.2%
VECTIVBIO HOLDING AG 8.7%
Value ($000) $52,931 Shares 3,113,600 Est. Cost $8.63 Unrealized
AEROVATE THERAPEUTICS INC 6.2%
Value ($000) $37,752 Shares 2,201,274 Est. Cost $15.75 Unrealized
ICOSAVAC, INC 6.0%
Value ($000) $36,778 Shares 3,703,704 Est. Cost $9.93 Unrealized
MDGL MADRIGAL PHARMACEUTICALS INC 5.7%
Value ($000) $34,631 Shares 149,917 Est. Cost $94.85 Unrealized +185.5%
TYRA TYRA BIOSCIENCES INC 5.6%
Value ($000) $33,874 Shares 1,989,103 Est. Cost $12.71 Unrealized +14.2%
KALV KALVISTA PHARMACEUTICALS, INC 5.0%
Value ($000) $30,559 Shares 3,395,495 Est. Cost $5.36 Unrealized +72.1%
VTYX VENTYX BIOSCIENCES, INC 4.4%
Value ($000) $26,756 Shares 815,724 Est. Cost $29.94 Unrealized +15.1%
DYN DYNE THERAPEUTICS, INC 3.0%
Value ($000) $18,564 Shares 1,650,150 Est. Cost $12.99 Unrealized -9.2%
KURA KURA ONCOLOGY INC 2.5%
Value ($000) $15,062 Shares 1,423,642 Est. Cost $14.54 Unrealized -18.7%
GPCR STRUCTURE THERAPEUTICS INC 2.4%
Value ($000) $14,550 Shares 350,000 Est. Cost $23.79 Unrealized
IMVT IMMUNOVANT, INC 2.0%
Value ($000) $12,423 Shares 654,853 Est. Cost $12.59 Unrealized +48.1%
SLN SILENCE THERAPEUTICS PLC 1.9%
Value ($000) $11,577 Shares 2,104,875 Est. Cost $10.03 Unrealized
ANTX AN2 Therapeutics, Inc. 1.8%
Value ($000) $10,959 Shares 1,289,320 Est. Cost $7.19 Unrealized 0.0%
TRDA ENTRADA THERAPEUTICS INC 1.5%
Value ($000) $8,856 Shares 584,955 Est. Cost $17.12 Unrealized
MERUS BV 1.3%
Value ($000) $7,899 Shares 300,000 Est. Cost $30.46 Unrealized
CABA CABALETTA BIO, INC 1.0%
Value ($000) $6,285 Shares 486,795 Est. Cost $3.64 Unrealized +198.1%
ACRS ACLARIS THERAPEUTICS INC 0.9%
Value ($000) $5,494 Shares 529,839 Est. Cost $15.07 Unrealized -39.9%
CCCC C4 THERAPEUTICS, INC. 0.6%
Value ($000) $3,511 Shares 1,276,574 Est. Cost $5.83 Unrealized -44.9%
ALPINE IMMUNE SCIENCES INC 0.4%
Value ($000) $2,602 Shares 253,069 Est. Cost $13.85 Unrealized